• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型 NF-κB 抑制剂(-)-DHMEQ 的有效细胞摄取和肿瘤细胞中 NF-κB 的不可逆抑制。

Efficient cellular uptake of the novel NF-kappaB inhibitor (-)-DHMEQ and irreversible inhibition of NF-kappaB in neoplastic cells.

机构信息

Department of Applied Chemistry, Faculty of Science and Technology, Keio University, Yokohama, Japan.

出版信息

Oncol Res. 2010;18(11-12):529-35. doi: 10.3727/096504010x12767359113721.

DOI:10.3727/096504010x12767359113721
PMID:20939428
Abstract

NF-kappaB is a transcription factor that induces the expression of inflammatory cytokines and antiapoptotic proteins. Earlier we designed a new NF-kappaB inhibitor, (-)-DHMEQ, and showed that it had potent anticancer and anti-inflammatory activities in various animal models without any toxicity. In the present research, we studied whether (-)-DHMEQ could be efficiently taken by cultured cells and irreversibly inhibit NF-kappaB by short time application to cultured cells. Even after mouse monocytic leukaemia RAW264.7 cells had been washed free of (-)-DHMEQ, lipopolysacharide (LPS)-induced activation of NF-kappaB in these cells was still inhibited. Moreover, topical application for 15 min was found to induce dormancy of the cells against LPS for 2-8 h. When it was topically added to RAW264.7 cells in which NF-kappaB was activated by LPS, the inhibition lasted at least for 2 h. NF-kappaB derectly upregulates expression of iNOS that produces NO. Short time application of (-)-DHMEQ also inhibited the function of cells in terms of NO production and iNOS induction in RAW264.7 cells. Thus, the fast incorporation of (-)-DHMEQ into the cells and irreversible inhibition of NF-kappaB by it were demonstrated, and this observation would explain its effective inhibition of certain functions in cellular and animal disease models.

摘要

NF-κB 是一种转录因子,可诱导炎症细胞因子和抗凋亡蛋白的表达。我们之前设计了一种新型 NF-κB 抑制剂(-)-DHMEQ,并在各种动物模型中证明其具有强大的抗癌和抗炎活性,且无任何毒性。在本研究中,我们研究了(-)-DHMEQ 是否可以被培养的细胞有效摄取,并通过短时间应用于培养的细胞来不可逆地抑制 NF-κB。即使在去除(-)-DHMEQ 后,脂多糖(LPS)仍能诱导 RAW264.7 细胞中的 NF-κB 激活。此外,我们发现 15 分钟的局部应用可诱导细胞对 LPS 的休眠 2-8 小时。当将其局部添加到 LPS 激活的 RAW264.7 细胞中时,抑制作用至少持续 2 小时。NF-κB 直接上调诱导型一氧化氮合酶(iNOS)的表达,从而产生 NO。(-)-DHMEQ 的短时间应用也抑制了 RAW264.7 细胞中 NO 产生和 iNOS 诱导的细胞功能。因此,证明了(-)-DHMEQ 快速掺入细胞并不可逆地抑制 NF-κB 的功能,这一观察结果可解释其在细胞和动物疾病模型中有效抑制某些功能的原因。

相似文献

1
Efficient cellular uptake of the novel NF-kappaB inhibitor (-)-DHMEQ and irreversible inhibition of NF-kappaB in neoplastic cells.新型 NF-κB 抑制剂(-)-DHMEQ 的有效细胞摄取和肿瘤细胞中 NF-κB 的不可逆抑制。
Oncol Res. 2010;18(11-12):529-35. doi: 10.3727/096504010x12767359113721.
2
Inhibition of macrophage activation and phagocytosis by a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin.新型NF-κB抑制剂去氢甲基环氧喹霉素对巨噬细胞活化和吞噬作用的抑制
Biomed Pharmacother. 2006 Nov;60(9):578-86. doi: 10.1016/j.biopha.2006.07.089. Epub 2006 Sep 1.
3
Inhibition of inflammatory mediator secretion by (-)-DHMEQ in mouse bone marrow-derived macrophages.(-)-DHMEQ对小鼠骨髓来源巨噬细胞炎症介质分泌的抑制作用
Biomed Pharmacother. 2009 Jun;63(5):351-8. doi: 10.1016/j.biopha.2008.05.003. Epub 2008 Jun 20.
4
Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.新型NF-κB抑制剂(-)-DHMEQ通过下调NFATc1抑制RANKL诱导的破骨细胞生成。
J Bone Miner Res. 2005 Apr;20(4):653-62. doi: 10.1359/JBMR.041213. Epub 2004 Dec 6.
5
A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.一种新型 NF-κB 抑制剂,去甲氧基表小檗碱,可改善小鼠的炎症性结肠损伤。
J Crohns Colitis. 2012 Mar;6(2):215-25. doi: 10.1016/j.crohns.2011.08.011. Epub 2011 Sep 21.
6
Inhibition of inflammatory cytokine secretion from mouse microglia cells by DHMEQ, an NF-kappaB inhibitor.NF-κB抑制剂DHMEQ对小鼠小胶质细胞炎性细胞因子分泌的抑制作用
Biomed Pharmacother. 2005 Jul;59(6):318-22. doi: 10.1016/j.biopha.2005.01.011.
7
A novel NF-kappaB inhibitor DHMEQ selectively targets constitutive NF-kappaB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo.一种新型核因子-κB抑制剂DHMEQ可选择性靶向组成型核因子-κB活性,并在体外和体内诱导多发性骨髓瘤细胞凋亡。
Int J Cancer. 2005 Mar 10;114(1):32-8. doi: 10.1002/ijc.20688.
8
Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.新型乳腺癌抑制剂去羟甲基环氧喹喔啉对核因子κB通路的靶向作用:体内抗肿瘤和抗血管生成潜力
Clin Cancer Res. 2005 Feb 1;11(3):1287-93.
9
Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells.一种新型核因子-κB激活抑制剂对膀胱癌细胞的抗肿瘤作用。
Expert Rev Anticancer Ther. 2003 Dec;3(6):793-8. doi: 10.1586/14737140.3.6.793.
10
Molecular design and biological activities of NF-kappaB inhibitors.NF-κB抑制剂的分子设计与生物学活性
Mol Cells. 2002 Oct 31;14(2):163-7.

引用本文的文献

1
Inhibition of Cellular and Animal Inflammatory Disease Models by NF-κB Inhibitor DHMEQ.NF-κB 抑制剂 DHMEQ 对细胞和动物炎症性疾病模型的抑制作用。
Cells. 2021 Sep 1;10(9):2271. doi: 10.3390/cells10092271.
2
Anticancer Activity of Novel NF-kappa B Inhibitor DHMEQ by Intraperitoneal Administration.新型 NF-κB 抑制剂 DHMEQ 通过腹腔给药的抗癌活性。
Oncol Res. 2020 Dec 10;28(5):541-550. doi: 10.3727/096504020X15929100013698. Epub 2020 Jun 23.
3
Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review.
NF-κB 抑制剂 DHMEQ 来源于微生物生物活性代谢物表环氧昆诺霉素:抑制癌症转移的晚期和早期阶段:综述。
Int J Mol Sci. 2018 Mar 3;19(3):729. doi: 10.3390/ijms19030729.
4
Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer.下调核因子κB激活是获得性铂耐药膀胱癌的一种有效治疗方式。
BMC Cancer. 2015 Apr 29;15:324. doi: 10.1186/s12885-015-1315-9.
5
IL10 receptor is a novel therapeutic target in DLBCLs.白细胞介素 10 受体是弥漫性大 B 细胞淋巴瘤的一个新的治疗靶点。
Leukemia. 2015 Aug;29(8):1684-94. doi: 10.1038/leu.2015.57. Epub 2015 Mar 3.
6
Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancer.去羟甲基表鬼臼毒素与吉西他滨联合作用对胰腺癌肝转移小鼠模型的影响。
Clin Exp Metastasis. 2013 Apr;30(4):381-92. doi: 10.1007/s10585-012-9544-7. Epub 2012 Oct 31.
7
(+)-Episesamin exerts anti-neoplastic effects in human hepatocellular carcinoma cell lines via suppression of nuclear factor-kappa B and inhibition of MMP-9.(+)-表芝麻素通过抑制核因子-κB 和基质金属蛋白酶-9 发挥抗人肝癌细胞系的肿瘤作用。
Invest New Drugs. 2012 Dec;30(6):2087-95. doi: 10.1007/s10637-011-9762-x. Epub 2011 Nov 3.